References
- Hofer K. Biophysical aspects of Auger processes: a review. Acta Oncol 1996; 35: 789–96.
- DeSombre E, Shafii B, Hanson R, Kuivanen P, Hughes A. Estrogen receptor-directed radiotoxicity with Auger electrons: specificity and mean lethal dose. Cancer Res 1992; 52: 5752–8.
- Schwartz J, Mustafi R, Hughes A, DeSombre E. DNA and chromosome breaks induced by iodine-123-labeled estrogen in Chinese hamster ovary cells. Radiat Res 1996; 146: 145–52.
- Kearney T, Hughes A, Hanson R, DeSombre E. Radiotoxic-ity of Auger electron-emitting estrogens in MCF-7 spheroids: a potential treatment for estrogen receptor-positive tumors. Radiat Res 1999; 151: 570–9.
- DeSombre E, Holt J, Herbst A. Steroid receptors in breast, uterine, and ovarian malignancy. Diagnostic and therapeutic applications. In: Gold J, Josimovich J, eds. Gynecologic endocrinology. New York: Plenum. 1987: 511–28.
- DeSombre E, Hughes A, Shafii B, et al. Estrogen receptor-di-rected radiotoxicity with Auger electron-emitting nuclides: E-17x-[1231]-iodoviny1-11fl-methoxyestradiol and CHO-ER cells. In: Howell R, Nara V, Sastry K, Rao D, eds. Biophysi-cal aspects of Auger processes. Woodbury, NY: American Institute of Physics Press. 1992: 352–71.
- Hughes A, Gatley S, DeSombre E. Comparison of the distri-bution of radioiodinated-E-17x-iodoviny1-11 -methoxyestra-diol and 2-iodo-1, 1-bis(4-hydroxypheny1)-phenylethylme estrogens in the immature female rat. J Nucl Med 1993; 34: 272–80.
- Greene G, Nolan C, Engler J, Jensen E. Monoclonal antibod-ies to human estrogen receptor. Proc Natl Acad Sci USA 1980; 77: 5115–9.
- DeSombre E, Pribish J, Hughes A. Comparison of the distri-bution of radioiodinated di- and trihydroxyphenylethylene estrogens in the immature female rat. Nucl Med Biol 1995; 22: 679–87.
- Herbst A. Neoplastic disease of the ovary. In: Droegemueller W, Herbst A, Mishell D, eds. Comprehensive gynecology. St Louis, MO: CF Mosby Co. 1987: 833–75.
- Bronzert D, Hochberg R, Lippman M. Specific cytotoxicity of 16x-r251]iodoestradiol for estrogen receptor-containing breast cancer cells. Endocrinology 1982; 110: 2177–9.
- McLaughlin W, Milius R, Pillai K, Edasery J, Blumenthal R, Bloomer W. Cytotoxicity of receptor-mediated 16x-[1251]iodoestradiol in cultured MCF-7 human breast cancer cells. J Nat Cancer Inst 1989; 81: 437–40.
- DeSombre E, Mease R, Hughes A, Harper P, DeJesus O, Friedman A. Bromine-80m-labeled estrogens: Auger electron-emitting, estrogen receptor-directed ligands with potential for therapy of estrogen receptor-positive cancers. Cancer Res 1988; 48: 899–906.
- DeSombre E, Harper P, Hughes A, et al. Bromine-80m radiotoxicity and the potential for estrogen receptor-di-rected therapy with Auger electrons. Cancer Res 1988; 48: 5805–89.
- Mease R, DeJesus 0, Gatley S, Harper P, DeSombre E, Friendman A. Production of no carrier added 8°mBr for investigation of Auger electron toxicity. (Int J Appl Ra-diat Isotopes (hit J Radiat Appl Instrum Part A) 1991; 42: 57–61.
- DeSombre E, Hughes A, Church-Landel C, Greene G, Schwartz J, Hanson R. Cellular and subcellular studies of the radiation effects of Auger electron-emitting estrogens. Acta Oncol 1996; 35: 33–40.